Clinical Trials Directory

Trials / Completed

CompletedNCT06638372

Caffeinated Chewing Gum on Special Forces Performance

Caffeinated Chewing Gum on Special Forces Performance: a Cross-over Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
16 (actual)
Sponsor
National Taiwan Sport University · Academic / Other
Sex
Male
Age
20 Years – 40 Years
Healthy volunteers
Accepted

Summary

The purpose of this project is to investigate the effects of caffeine chewing gum on the cognitive functions and special operations capabilities of special forces.

Detailed description

Using a randomisation crossover design, 20-40 active-duty special forces members who had undergone leave and special forces reserve training were divided into a caffeine trial (CAF) and a placebo trail (PL). After chewing caffeine-containing gum containing 5 mg/kg (CAF group) or caffeine-free gum (PL group) for 15 minutes, then performed a simple reaction test, a stroop test, a visual search test, a grip strength test, a vertical jump test, a 20-metre sprint test, and a counter-terrorism simulation test. A heart rate monitor was used to measure the heart rate and heart rate variability of the participants. Saliva samples were collected and analysed for α-Amylase, cortisol and caffeine concentrations before the test, after a 15-minute break from chewing gum and at the end of the test. Completion time of cognitive functions, grip strength, vertical jump height, 20 m sprint time, time to completion of the counterterrorism simulation test, and target score will be analysed using paired-sample t-tests.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTcaffeineThe participants chewing either caffeine Gum (CAF trial, containing 3 mg/kg of caffeine) or Placebo Gum (PL) for 10 minutes. After rested for 15 minutes, the participants underwent tests.

Timeline

Start date
2024-10-05
Primary completion
2024-10-06
Completion
2025-05-30
First posted
2024-10-15
Last updated
2025-06-26

Locations

1 site across 1 country: Taiwan

Source: ClinicalTrials.gov record NCT06638372. Inclusion in this directory is not an endorsement.